FrancophonIA/ELRC3.0 huggingface dataset:
English: Seretide Evohaler and associated names (see Annex I) 25/50 microgram/dose pressurised inhalation, suspension
Estonian: Seretide Evohaler ja sarnased nimetused (vt lisa I), 25/50 mikrogrammi/annus, inhaleeritav aerosool, suspensioon
English: Seretide Evohaler and associated names (see Annex I) 25/250 microgram/dose pressurised inhalation, suspension.
Estonian: SERETIDE EVOHALER ja sarnased nimetused (Vaata Lisa I), 25/250 µg inhaleeritav aerosool, suspensioon.
English: Seretide Evohaler and associated names (see Annex I) 25/250 microgram/dose pressurised inhalation, suspension [See Annex I - To be completed nationally]
Estonian: SERETIDE EVOHALER ja sarnased nimetused (vt lisa I), 25/250 mikrogrammi/annus, inhaleeritav aerosool, suspensioon [Vt lisa I - täidetakse riiklikult]
English: Seretide Evohaler and associated names (see Annex I) 25/50 microgram/dose pressurised inhalation, suspension [See Annex I - To be completed nationally]
Estonian: SERETIDE EVOHALER ja sarnased nimetused (vt lisa I), 25/50 mikrogrammi/annus, inhaleeritav aerosool, suspensioon [Vt lisa I - täidetakse riiklikult]
English: Seretide Evohaler and associated names (see Annex I) 25/125 microgram/dose pressurised inhalation, suspension.
Estonian: SERETIDE EVOHALER ja sarnased nimetused (Vaata Lisa I), 25/125 µg inhaleeritav aerosool, suspensioon.
English: Seretide does not work in controlling sudden attacks of breathlessness and wheezing where you would need to use your fast acting ‘rescue' medication.
Estonian: Seretide ei sobi järsku tekkivate hingamisraskuste ja viliseva hingamise leevendamiseks.
English: Seretide Evohaler and associated names (see Annex I) 25/50 microgram/dose pressurised inhalation, suspension.
Estonian: SERETIDE EVOHALER ja sarnased nimetused (Vaata Lisa I), 25/50 µg inhaleeritav aerosool, suspensioon.
English: Once control of asthma is attained treatment should be reviewed and consideration given as to whether patients should be stepped down to an inhaled corticosteroid alone.
Estonian: Pärast astma kontrolli alla saamist, peab ravi uuesti üle vaatama.
English: It is important to take Seretide as your doctor recommended.
Estonian: Kui te kasutate Seretide't rohkem kui ette nähtud Tähtis on Seretide't manustada täpselt arsti soovituse kohaselt.
English: PHARMACEUTICAL FORM AND CONTENTS Pressurised inhalation, suspension 1 X 120 puffs
Estonian: 1 x 120 annust inhalaatoris
English: Patients should consider getting a replacement when the counter shows the number 020.
Estonian: Kui annuselugeja näit on 020, tuleb mõelda uue inhalaatori hankimisele.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Xiapex on 28 February 2011.
Estonian: Euroopa Komisjon andis Xiapexi müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, 28. veebruaril
English: A risk management plan has been developed to ensure that Xiapex is used as safely as possible.
Estonian: Töötati välja riskijuhtimiskava, et tagada Xiapexi võimalikult ohutu kasutamine.
English: What measures are being taken to ensure the safe and effective use of Xiapex?
Estonian: Mis meetmed võetakse, et tagada Xiapexi ohutu ja efektiivne kasutamine?
English: The full EPAR for Xiapex can be found on the Agency's website ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Estonian: Euroopa avaliku hindamisaruande täistekst Xiapexi kohta on ameti veebilehel: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: These reactions were mostly mild to moderate in severity and generally subsided within one to two weeks.
Estonian: Reaktsioonid olid enamasti kerged kuni mõõdukad ja kadusid üldiselt ühe-kahe nädala jooksul.
English: Other information about Xiapex
Estonian: Muu teave Xiapexi kohta
English: Dupuytren's contracture is a condition where one or more fingers are bent forwards toward the palm and cannot be fully straightened.
Estonian: Dupuytreni kontraktuur on haigus, kus üks või mitu sõrme on kõverdunud peopesa poole ja neid ei saa täielikult sirgu ajada.
English: The patients were treated with three injections and their hands were examined three months after the last injection to see how much the finger joints could be straightened out.
Estonian: Patsiente raviti kolme süstiga ja kolm kuud pärast viimast süsti vaadati nende käed üle, et kontrollida, kui sirgeks saab sõrmeliigesed painutada.
English: Patients should subsequently continue modeling procedures daily at home as instructed for the rest of the cycle.
Estonian: Seejärel peavad patsiendid modelleerimisprotseduuri kodus jätkama, tehes seda juhiste järgi tsükli ülejäänud päevade jooksul.
English: The most common side effects seen with Xiapex were local injection site reactions such as swelling, bruising, bleeding and pain.
Estonian: Xiapexi kõige sagedamad kõrvalnähud olid süstekoha paiksed reaktsioonid, nagu turse, verevalum, veritsus ja valu.
English: Injection site reactions were very common, occurring in the vast majority of patients.
Estonian: Süstekoha reaktsioone esines väga sageli: neid ilmnes patsientide enamikul.
English: The CHMP decided that Xiapex's benefits are greater than its risks and recommended that it be given marketing authorisation.
Estonian: Inimravimite komitee otsustas, et Xiapexi kasulikkus on suurem kui sellega kaasnevad riskid, ja soovitas anda ravimi müügiloa.
English: If injection and finger extension have not brought about a satisfactory response, the procedure may be repeated at monthly intervals up to a maximum of 3 injections per cord.
Estonian: Kui ühe süsti ja sõrmevenitusega ei saavutata rahuldavat tulemust, võib protseduuri korrata kuuajaliste intervallidega, tehes kuni 3 süsti väädi kohta.
English: Around 24 hours after the injection, the finger can then be straightened by the doctor, by performing a ‘finger extension procedure' whereby it is stretched out for around 10 to 20 seconds to help disrupt the cord.
Estonian: Ligikaudu 24 tundi pärast süsti võib arst teha sõrme sirgestamiseks sõrmevenitusprotseduuri, mille käigus sõrm tõmmatakse ligikaudu 10-20 sekundiks sirgu, et väädi katkemist hõlbustada.
English: For patients with Peyronie's disease, Xiapex is given for up to 4 treatment cycles each lasting about 6 weeks.
Estonian: Peyronie' tõvega patsientidele manustatakse Xiapexi kuni 4 ravitsüklit, millest igaüks kestab ligikaudu 6 nädalat.
English: This is a summary of the European public assessment report (EPAR) for Xiapex.
Estonian: See on ravimi Xiapex Euroopa avaliku hindamisaruande kokkuvõte.
English: Patients received up to 4 treatment cycles, each involving two injections and subsequent modeling procedures, and the effects were measured on follow-up after 1 year.
Estonian: Patsiendid läbisid kuni 4 ravitsüklit, millest igaüks koosnes kahest süstist ja järgnevast modelleerimisprotseduurist, ning ravimi toimet mõõdeti järelkontrollis 1 aasta pärast.
English: Xiapex was also more effective than placebo in treating Peyronie's disease, producing a 38% and 31% improvement in abnormal curvature in the two studies, compared with 21% and 15% respectively for placebo.
Estonian: Xiapex oli platseebost efektiivsem ka Peyronie' tõve ravis, andes kahes uuringus tulemuseks ebanormaalse kõveruse paranemise 38% ja 31% võrra, võrreldes vastavalt 21% ja 15%ga platseebo kasutamisel.
English: Xiapex collagenase clostridium histolyticum
Estonian: Xiapex bakteri Clostridium histolyticum kollagenaas
English: Peyronie's disease is a condition in which men develop plaques of fibrous, scar-like tissue in their penis, causing it to become abnormally curved, and sometimes leading to pain or difficulty in sexual intercourse.
Estonian: Peyronie' tõbi on haigus, mille korral arenevad meestel peenises kiulised, armkudet meenutavad naastud, mis põhjustavad peenise ebanormaalset kõverdumist ning mõnikord valu või raskusi suguühte ajal.
English: In the second study the figures were 44% (20 out of 45) for the Xiapex group and 5% (1 out of 21) for the placebo group.
Estonian: Teises uuringus olid vastavad näitajad Xiapexi rühmas 44% (20 patsienti 45st) ja platseeborühmas 5% (1 patsient 21st).
English: For the full list of all side effects and restrictions with Xiapex, see the package leaflet.
Estonian: Xiapexi kohta teatatud kõrvalnähtude ja piirangute täielik loetelu on pakendi infolehel.
English: Xiapex was compared with placebo (a dummy treatment) in two main studies involving a total of 374 adult patients with Dupuytren's contracture.
Estonian: Xiapexi võrreldi platseeboga (näiv ravim) kahes põhiuuringus, kus osales kokku 374 Dupuytreni kontraktuuriga täiskasvanud patsienti.
English: What is Xiapex?
Estonian: Mis on Xiapex?
English: In each cycle, the dose of Xiapex is injected into the plaque causing the deformity followed by a second injection given 1 to 3 days after the first.
Estonian: Igas tsüklis süstitakse Xiapexi annus deformatsiooni põhjustavasse naastu ning 1-3 päeva pärast esimest süsti tehakse teine süst.
English: The main measures of effectiveness were the reduction in the abnormal curvature of the penis and the extent to which the condition was bothersome to the patient.
Estonian: Efektiivsuse põhinäitaja oli peenise enanormaalse kõveruse vähenemine ja haigusest tingitud ebamugavuse määr patsiendi jaoks.
English: For more information about treatment with Xiapex, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate Xiapexiga toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: Xiapex is used in patients with plaques that can be felt through the skin and in whom the abnormal curvature of the penis is at least 30 degrees at the start of therapy.
Estonian: Xiapexi kasutatakse läbi naha tuntavate naastudega patsientidel, kelle peenise ebanormaalne kõverus on ravi alguses vähemalt 30 kraadi.
English: The company must carry out an educational programme for doctors on the correct use and the potential side effects associated with the medicine.
Estonian: Ravimi tootja kohustub pakkuma arstidele õppeprogrammi ravimi õige kasutamise ja võimalike kõrvalnähtude kohta.
English: Why has Xiapex been approved?
Estonian: Miks Xiapex heaks kiideti?
English: Among patients who completed the first study, 64% (130 out of 203) of those receiving Xiapex could straighten their fingers to an angle of 5 degrees or less compared with 7% (7 out of 103) of patients receiving placebo.
Estonian: Esimese uuringu läbinud patsiente, kes suutsid sirgendada sõrmi, nii et sõrmeliigese paindenurk oli 5° või vähem, oli Xiapexi rühmas 64% (130 patsienti 203st) ja platseeborühmas 7% (7 patsienti 103st).
English: Xiapex contains a mixture of two ‘collagenases', enzymes that break up collagen.
Estonian: Xiapex sisaldab kahe kollagenaasi ehk kollageeni lagundava ensüümi segu.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Xiapex, including the appropriate precautions to be followed by healthcare professionals and patients.
Estonian: Selle alusel lisati Xiapexi omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
English: For Dupuytren's contracture, the doctor injects the appropriate dose of Xiapex directly into a cord in the patient's palm.
Estonian: Dupuytreni kontraktuuri korral süstib arst sobiva annuse Xiapexi otse patsiendi peopesas olevasse vääti.
English: What is the risk associated with Xiapex?
Estonian: Mis riskid Xiapexiga kaasnevad?
English: Xiapex must not be used to treat Peyronie's disease if the plaque affects the urethra (the tube that carries urine and semen to the outside).
Estonian: Xiapexi ei tohi kasutada Peyronie' tõve raviks, kui naastud mõjutavad kusitit (uriini ja sperma väljutuskanal).
English: For Peyronie's disease, Xiapex was compared with placebo in two further studies involving 832 men.
Estonian: Peyronie' tõve ravis võrreldi Xiapexi platseeboga kahes lisauringus, milles osales 832 meest.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Xiapex.
Estonian: Selles selgitatakse, kuidas inimravimite komitee hindas ravimit ja otsustas toetada müügiloa andmist; samuti esitatakse komitee soovitused, kuidas ravimit kasutada.
English: Xiapex is to be used in patients with cords in their palms that are thick enough to be felt through the skin.
Estonian: Xiapexi kasutatakse patsientidel, kellel on peopesas nii paksud väädid, et need on läbi naha tunda.
English: The company that markets Xiapex must also ensure that all doctors expected to use the medicine are properly trained on the use of the medicine and experienced in diagnosing and managing Dupuytren's contracture or Peyronie's disease.
Estonian: Xiapexi tootja peab samuti tagama, et kõik ravimit kasutavad arstid on saanud ravimi kasutamiseks korraliku ettevalmistuse ning nad on Dupuytreni kontraktuuri või Peyronie' tõve diagnoosimises ja ravis kogenud.
English: The main measure of effectiveness was the proportion of patients whose main affected joint could be straightened so that it was bent forwards by no more than 5 degrees.
Estonian: Efektiivsuse põhinäitaja oli selliste patsientide osakaal, kelle haigusest kõige rohkem haaratud sõrmeliigest sai sirgendada sedavõrd, et selle paindenurk oli 5° või väiksem.
English: For more information on the use of Xiapex, including instructions on finger extension and penile modeling procedures, see the summary of product characteristics (also part of the EPAR).
Estonian: Xiapexi kasutamise üksikasjalik teave, sh sõrmevenituse ja peenise modelleerimise protseduuride juhised, on ravimi omaduste kokkuvõttes (mis on samuti Euroopa avaliku hindamisaruande osa).
English: Xiapex is used to treat Dupuytren's contracture and Peyronie's disease in adults.
Estonian: Xiapexi kasutatakse Dupuytreni kontraktuuri ja Peyronie' tõve raviks täiskasvanutel.
English: The collagenases in Xiapex are extracted from the bacterium Clostridium histolyticum.
Estonian: Xiapexis sisalduvad kollagenaasid on eraldatud bakterist Clostridium histolyticum.
English: This weakens and disrupts the cord or plaque.
Estonian: Nii muutub väät või naast nõrgemaks ja katkeb.
English: Xiapex must be given by a doctor trained in the use of the medicine and experienced in diagnosing and managing Dupuytren's contracture or male genital problems.
Estonian: Xiapexi peab manustama arst, kes on saanud ettevalmistuse ravimi kasutamiseks ja kes on kogenud Dupuytreni kontraktuuri või meeste suguelundite probleemide diagnoosimises ja ravis.
English: A ‘penile modeling procedure' is then performed by the doctor after a further 1 to 3 days to gently stretch and bend the plaque in the opposite direction to the abnormal curvature.
Estonian: 1-3 päeva pärast teist süsti viib arst läbi nn peenise modelleerimise protseduuri, õrnalt venitades ja painutades naastu ebanormaalsele kõverusele vastupidises suunas.
English: Up to 2 cords or 2 affected joints in the same hand can be treated at a time.
Estonian: Korraga saab ravida ühe käe kuni 2 vääti või 2 mõjutatud liigest.
English: It is caused by a thickening of the tissues under the skin of the palm that form ‘cords' pulling down on the fingers.
Estonian: Seda haigust põhjustab peopesa nahaaluste kudede kootumine, mille tagajärjel moodustuvad väädid, mis kõverdavad sõrmi.
English: Xiapex was shown to be more effective at treating Dupuytren's contracture than placebo.
Estonian: Uuringutes selgus, et Xiapex on Dupuytreni kontraktuuri ravis efektiivsem kui platseebo.
English: When injected into a cord or a plaque, the collagenases break up the collagen fibres.
Estonian: Vääti või naastu süstituna hakkavad kollagenaasid kollageenikiude lagundama.
English: There was also a greater improvement with Xiapex than placebo in patient-reported scores of how bothersome the condition was after treatment.
Estonian: Xiapexi paremust platseebo suhtes näitasid ka ravijärgsed patsiendihinnangud haigusest tingitud ebamugavuse kohta.
English: How does Xiapex work?
Estonian: Kuidas Xiapex toimib?
English: What benefit has Xiapex shown during the studies?
Estonian: Milles seisneb uuringute põhjal Xiapexi kasulikkus?
English: The cords in the palm of patients with Dupuytren's contracture and the plaques in Peyronie's disease are made of fibres of a protein called collagen.
Estonian: Väädid Dupuytreni kontraktuuriga patsientide peopesas ja naastud Peyronie' tõvega patsientidel koosnevad kollageenvalgu kiududest.
English: It contains the active substance collagenase clostridium histolyticum.
Estonian: Ravimi toimeaine on bakteri Clostridium histolyticum kollagenaas.
English: What is Xiapex used for?
Estonian: Milleks Xiapexi kasutatakse?
English: How is Xiapex used?
Estonian: Kuidas Xiapexi kasutatakse?
English: Xiapex is a powder and solvent that are made up into a solution for injection.
Estonian: Xiapex on süstelahuse pulber ja lahusti.
English: How has Xiapex been studied?
Estonian: Kuidas Xiapexi uuriti?
English: Do this at a speed that is comfortable for you.
Estonian: Tehke seda kiirusel, mis on teie jaoks mugav.
English: It may harm them,
Estonian: Asetage pen-süstel nahale
English: You may also see one or more air bubbles.
Estonian: Samuti võite näha ühte või mitut õhumullikest.
English: Date of first authorisation: 10 November 2017
Estonian: Müügiloa esmase väljastamise kuupäev: 10. november 2017
English: However, the physician should ensure appropriate medical follow-up of patients.
Estonian: Siiski peab arst tagama patsientide sobiva meditsiinilise jälgimise.
English: Your injection is now complete!
Estonian: Teie süste on nüüd tehtud!
English: If you stop treatment, symptoms of psoriasis may come back.
Estonian: Kui te lõpetate ravi, võivad psoriaasi sümptomid tagasi tulla.
English: Patients were examined at four week intervals for a total of four visits.
Estonian: Patsiente uuriti neljanädalaste intervallidega kokku neljal visiidil.
English: • if you have an active infection, including active tuberculosis
Estonian: • kui teil on aktiivne infektsioon, kaasa arvatud aktiivne tuberkuloos
English: No data are available on the response to live or inactive vaccines.
Estonian: Puuduvad andmed immuunvastuse kohta elus- või inaktiveeritud vaktsiinidele.
English: No specific studies have been conducted in elderly patients.
Estonian: Eakatel patsientidel ei ole spetsiifilisi uuringuid läbi viidud.
English: • if you have tuberculosis or have been in close contact with someone with tuberculosis
Estonian: • kui teil on tuberkuloos või teil on olnud lähedane kontakt kellegagi, kellel on tuberkuloos
English: Wash your hands well with soap and warm water.
Estonian: Peske käed hoolikalt seebi ja sooja veega.
English: Injection is complete when the handle is pushed all the way down, you hear a click, and the green body is no longer visible.
Estonian: Süstimine on lõppenud, kui käepide on kogu pikkuses alla vajutatud, te kuulete klõpsu ning roheline korpus ei ole enam nähtav.
English: Tremfya has not been studied in these patient populations.
Estonian: Tremfya't ei ole nendes patsiendirühmades uuritud.
English: Herpes simplex infections
Estonian: Herpes simplex infektsioonid
English: The key efficacy results for the primary and major secondary study endpoints are shown in Table 2 below.
Estonian: Efektiivsuse võtmetulemused esmaste ja sekundaarsete uuringu tulemusnäitajate järgi on esitatud tabelis 2 allpool.
English: 2333CB Leiden The Netherlands
Estonian: 2333CB Leiden Holland
English: Talk to your doctor if you are pregnant, think you may be pregnant or are planning to have a baby.
Estonian: Rääkige oma arstiga, kui te olete rase, arvate end olevat rase või kavatsete rasestuda.
English: Clinically important active infections (e.g., active tuberculosis, see section 4.4).
Estonian: Kliiniliselt olulised aktiivsed infektsioonid (nt aktiivne tuberkuloos, vt lõik 4.4).
English: Human IgGs are known to be excreted in breast milk during the first few days after birth, and decrease to low concentrations soon afterwards; consequently, a risk to the breast-fed infant during this period cannot be excluded.
Estonian: Teadaolevalt erituvad inimese IgG-d rinnapiima esimese paari sünnitusjärgse päeva jooksul ning seejärel väheneb nende hulk kiiresti väikeste kontsentratsioonideni; seega ei saa sel perioodil välistada riski rinnaga toidetavale lapsele.
English: In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.
Estonian: Et parandada bioloogiliste ravimpreparaatide kasutamise jälgitavust, tuleb manustatud preparaadi kaubanduslik nimetus ja partii number selgelt dokumenteerida.
English: Baseline characteristics for randomised patients were similar to those observed in VOYAGE 1 and 2.
Estonian: Randomiseeritud patsientide ravieelsed tunnused olid sarnased nendega, mida täheldati uuringutes VOYAGE 1 ja 2.
English: • Tremfya should not be used in pregnancy as the effects of this medicine in pregnant women are not known.
Estonian: • Tremfya't ei tohi kasutada raseduse ajal, sest selle ravimi mõju rasedatele naistele on teadmata.
English: • After the first dose, you will have the next dose 4 weeks later, and then every 8 weeks.
Estonian: • Pärast esimest annust saate te järgmise annuse 4 nädalat hiljem ning edaspidi iga 8 nädala järel.
English: Do not remove until you are ready to inject Tremfya (See Step 2).
Estonian: Ärge eemaldage nõelakatet enne, kui olete valmis Tremfya't süstima (vt punkt 2).
English: Tell your doctor or pharmacist:
Estonian: Rääkige oma arstile või apteekrile:
English: Tremfya may increase the risk of infection.
Estonian: Tremfya võib suurendada infektsiooniriski.
English: The safety and efficacy of Tremfya in children and adolescents below the age of 18 years have not yet been established.
Estonian: Tremfya ohutus ja efektiivsus alla 18-aastastel lastel ja noorukitel ei ole veel tõestatud.
English: The following side effects are all mild to moderate.
Estonian: Järgmised kõrvaltoimed võivad olla kerged kuni mõõdukad.
English: Select from the following areas for your injection:
Estonian: Valige süstimiseks üks järgmistest piirkondadest:
English: Pharmacotherapeutic group: Immunosuppressants, interleukin inhibitors, ATC code: L04AC16.
Estonian: Farmakoterapeutiline rühm: immunosupressandid, interleukiini inhibiitorid, ATC-kood: L04AC16.
English: • if you are allergic to guselkumab or any of the other ingredients of this medicine (listed in section 6).
Estonian: • kui olete guselkumabi või selle ravimi mis tahes koostisosade (loetletud lõigus 6) suhtes allergiline.
English: Tremfya is not recommended for children and adolescents under 18 years of age because it has not been studied in this age group.
Estonian: Tremfya't ei ole soovitatav kasutada lastel ja alla 18-aastastel noorukitel, sest seda ei ole selles vanuserühmas uuritud.
English: Keep Tremfya and all medicines out of reach of children.
Estonian: Hoidke Tremfya't ja kõiki teisi ravimeid laste eest kättesaamatus kohas.
English: Some side effects are very common (may affect more than 1 in 10 people): - upper respiratory infections
Estonian: Mõned kõrvaltoimed esinevad väga sageli (võivad esineda rohkem kui 1 inimesel 10-st): - ülemiste hingamisteede infektsioonid
English: • if you have an infection that does not go away or that keeps coming back
Estonian: • kui teil on infektsioon, mis ei taandu või kipub korduma
English: As a precautionary measure, it is preferable to avoid the use of Tremfya in pregnancy.
Estonian: Ettevaatusabinõuna on parem vältida Tremfya kasutamist raseduse ajal.
English: It is important not to try to inject yourself until you have been trained by your doctor or nurse.
Estonian: On tähtis, et te ei prooviks ravimit endale ise süstida enne, kui olete saanud väljaõppe oma arsti või meditsiiniõe juhendamisel.
English: How much Tremfya is given and for how long Your doctor will decide for how long you need to use Tremfya.
Estonian: Kui palju Tremfya't teile manustatakse ja kui kaua Teie arst otsustab, kui kaua te Tremfya't peate kasutama.